OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Advancing the science on cannabis concentrates and behavioural health
L. Cinnamon Bidwell, Renée Martin‐Willett, Hollis C. Karoly
Drug and Alcohol Review (2021) Vol. 40, Iss. 6, pp. 900-913
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Lower-Risk Cannabis Use Guidelines (LRCUG) for reducing health harms from non-medical cannabis use: A comprehensive evidence and recommendations update
Benedikt Fischer, Tessa Robinson, Chris Bullen, et al.
International Journal of Drug Policy (2021) Vol. 99, pp. 103381-103381
Open Access | Times Cited: 136

State Cannabis Legalization and Cannabis Use Disorder in the US Veterans Health Administration, 2005 to 2019
Deborah S. Hasin, Melanie M. Wall, C. Jean Choi, et al.
JAMA Psychiatry (2023) Vol. 80, Iss. 4, pp. 380-380
Open Access | Times Cited: 23

Adult use of highly-potent Δ9-THC cannabis concentrate products by U.S. state cannabis legalization status, 2021
Deborah S. Hasin, Jacob T. Borodovsky, Dvora Shmulewitz, et al.
Addictive Behaviors (2023) Vol. 140, pp. 107617-107617
Open Access | Times Cited: 20

How should policymakers regulate the tetrahydrocannabinol content of cannabis products in a legal market?
Wayne Hall, Janni Leung, Beatriz H. Carlini
Addiction (2023) Vol. 118, Iss. 6, pp. 998-1003
Open Access | Times Cited: 17

Use of highly-potent cannabis concentrate products: More common in U.S. states with recreational or medical cannabis laws
Deborah S. Hasin, Jacob T. Borodovsky, Dvora Shmulewitz, et al.
Drug and Alcohol Dependence (2021) Vol. 229, pp. 109159-109159
Open Access | Times Cited: 33

Drugs of Misuse: Focus on Vascular Dysfunction
Holly R. Middlekauff, Ziva D. Cooper, Sasha B. Strauss
Canadian Journal of Cardiology (2022) Vol. 38, Iss. 9, pp. 1364-1377
Open Access | Times Cited: 26

The impact of recreational cannabis legalization on youth: the Colorado experience
Jesse D. Hinckley, Devika Bhatia, Jarrod M. Ellingson, et al.
European Child & Adolescent Psychiatry (2022) Vol. 33, Iss. 3, pp. 637-650
Open Access | Times Cited: 20

High-Potency Cannabis Use and Health: A Systematic Review of Observational and Experimental Studies
Stephanie Lake, Conor H. Murray, Brittany A. Henry, et al.
American Journal of Psychiatry (2025)
Closed Access

Education, Training, and Perceptions of Physician Competency Among Medical Cannabis Patients in Israel
Yuval Zolotov, Offer E. Edelstein, Leslie Mendoza Temple, et al.
Complementary Therapies in Medicine (2025), pp. 103172-103172
Open Access

Pot at the End of the Rainbow: Cannabis Use Among Sexual Minorities
Kyle Schofield, Carrie Cuttler, Bradley T. Conner, et al.
Cannabis and Cannabinoid Research (2023) Vol. 8, Iss. 5, pp. 942-948
Closed Access | Times Cited: 10

Age differences in patterns of cannabis use among an online US sample of adults who consume cannabis frequently
Ofir Livne, Alan J. Budney, Jacob T. Borodovsky, et al.
The American Journal of Drug and Alcohol Abuse (2024) Vol. 50, Iss. 2, pp. 242-251
Closed Access | Times Cited: 3

Typical Hits, Grams, or Joints: Evaluating Cannabis Survey Measurement Strategies for Quantifying Consumption
Jacob T. Borodovsky, Deborah S. Hasin, Dvora Shmulewitz, et al.
Cannabis and Cannabinoid Research (2022) Vol. 9, Iss. 2, pp. 646-658
Closed Access | Times Cited: 15

Gender Differences in Dual Diagnoses Associated with Cannabis Use: A Review
Laura Prieto-Arenas, Ignacio Díaz, M. Carmen Arenas
Brain Sciences (2022) Vol. 12, Iss. 3, pp. 388-388
Open Access | Times Cited: 13

Acute objective and subjective intoxication effects of legal-market high potency THC-dominant versus CBD-dominant cannabis concentrates
Meggan L. Drennan, Hollis C. Karoly, Angela D. Bryan, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 16

Cannabinoid Therapy in Athletics: A Review of Current Cannabis Research to Evaluate Potential Real-World Cannabinoid Applications in Sport
E Thompson, Jane Alcorn, J. Patrick Neary
Sports Medicine (2024) Vol. 54, Iss. 11, pp. 2743-2769
Closed Access | Times Cited: 2

Cannabis Use Disorder: A Behavioral Economic Perspective
Elizabeth R. Aston, Benjamin L. Berey
Current Addiction Reports (2022) Vol. 9, Iss. 1, pp. 1-13
Open Access | Times Cited: 11

A daily diary investigation of cannabis use and its diet and exercise correlates
Laurel P. Gibson, Carillon J. Skrzynski, G Giordano, et al.
Frontiers in Psychology (2023) Vol. 14
Open Access | Times Cited: 6

Cannabis vaporisation: Understanding products, devices and risks
Caroline A. MacCallum, Lindsay A. Lo, Carly A. Pistawka, et al.
Drug and Alcohol Review (2023) Vol. 43, Iss. 3, pp. 732-745
Open Access | Times Cited: 5

Measuring the diversity gap of cannabis clinical trial participants compared to people who report using cannabis
Heather M. Barkholtz, M Bates
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 4

Identifying policy options to regulate high potency cannabis: A multiple stakeholder concept mapping study in Washington State, USA
Beatriz H. Carlini, Sharon B. Garrett, Patrick Matos, et al.
International Journal of Drug Policy (2023) Vol. 123, pp. 104270-104270
Closed Access | Times Cited: 4

Nicotine and Alcohol Use as Predictors of Recreational Cannabis Use in Adolescence: A Systematic Review and Narrative Synthesis
Tina Fingesi, Linda Jepkoech Kimaru, B. O. Okusanya, et al.
Substance Use & Misuse (2024) Vol. 59, Iss. 9, pp. 1367-1382
Closed Access | Times Cited: 1

Cannabis flower, concentrates, and edibles: a narrative review comparing prevalence of use, methods of consumption, and cannabis use disorder outcomes
Arpana G. Inman, Anita Cservenka
Journal of Addictive Diseases (2024), pp. 1-11
Closed Access | Times Cited: 1

Call to Action for Enhanced Equity and Inclusion in Cannabis Research
Renée Martin‐Willett, L. Cinnamon Bidwell
Cannabis and Cannabinoid Research (2021) Vol. 6, Iss. 2, pp. 77-81
Open Access | Times Cited: 8

Baseline affective symptomatology moderates acute subjective effects of high potency THC and CBD cannabis concentrates.
Renée Martin‐Willett, Carillon J. Skrzynski, Hollis C. Karoly, et al.
Experimental and Clinical Psychopharmacology (2023) Vol. 31, Iss. 6, pp. 1039-1049
Closed Access | Times Cited: 2

Cannabis Use Patterns and Related Health Outcomes Among Spanish Speakers in the United States and Internationally.
Renée Martin‐Willett, Elizabeth Zambrano Garza, L. Cinnamon Bidwell
PubMed (2022) Vol. 95, Iss. 3, pp. 327-341
Closed Access | Times Cited: 4

Page 1 - Next Page

Scroll to top